Exploring the link between intimate partner violence and HIV prevention in transgender and nonbinary individuals
Intimate Partner Violence and HIV Prevention Continuum Engagement Among Transgender and Nonbinary Populations
['FUNDING_R01'] · SAN DIEGO STATE UNIVERSITY · NIH-10927390
This study is looking at how experiences of intimate partner violence can affect HIV testing and prevention among transgender and nonbinary people, with the goal of finding ways to better support their health and safety.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | SAN DIEGO STATE UNIVERSITY (nih funded) |
| Locations | 1 site (SAN DIEGO, UNITED STATES) |
| Trial ID | NIH-10927390 on ClinicalTrials.gov |
What this research studies
This research investigates how intimate partner violence (IPV) affects HIV testing and prevention behaviors among transgender and nonbinary (TGNB) populations. It aims to understand the relationship dynamics and experiences of IPV that may influence sexual risk behaviors and access to HIV prevention methods like pre-exposure prophylaxis (PrEP). By employing qualitative methodologies, the study will gather insights from diverse TGNB individuals over a 24-month period to identify specific IPV forms and their impact on HIV risk. The findings could help tailor interventions to improve health outcomes for TGNB individuals facing IPV.
Who could benefit from this research
Good fit: Ideal candidates for this research are transgender and nonbinary individuals who have experienced intimate partner violence and are at risk for HIV.
Not a fit: Patients who do not identify as transgender or nonbinary or who have not experienced intimate partner violence may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved HIV prevention strategies specifically designed for transgender and nonbinary individuals affected by intimate partner violence.
How similar studies have performed: While there is existing research on IPV and HIV risk, this study's focus on the unique experiences of TGNB populations represents a novel approach.
Where this research is happening
SAN DIEGO, UNITED STATES
- SAN DIEGO STATE UNIVERSITY — SAN DIEGO, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: STORHOLM, ERIK D. — SAN DIEGO STATE UNIVERSITY
- Study coordinator: STORHOLM, ERIK D.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus